Last reviewed · How we verify
NCT03490305: Exlap
Penetrating Abdominal Injuries From the Battle of Mosul
trial testing Exploratory laparotomy in Penetrating Abdominal Trauma in 77 participants. Completed in 10 October 2018.
9 October 2018
Quick facts
| Lead sponsor | Vrinnevi Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 77 |
| Start date | 11 November 2017 |
| Primary completion | 9 October 2018 |
| Estimated completion | 10 October 2018 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Exploratory laparotomy
Conditions studied
- Penetrating Abdominal Trauma — all drugs for Penetrating Abdominal Trauma →
- War Injury — all drugs for War Injury →
Sponsor
Vrinnevi Hospital
Who can join
Eligibility, any sex, with Penetrating Abdominal Trauma or War Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The battle of Mosul was characterized by the use of improvised explosive devices, human shields and suicide bombers in an urban setting. It is unclear whether this type of warfare cause more extensive abdominal injuries to civilians than combatants. All patients admitted with penetrating abdominal injury subjected to an exploratory laparotomy at Emergency Hospital, Erbil, between October 17, 2016 and July 16, 2017 will be included. Differences in demographics, injury mechanism, time since injury, clinical status on arrival, intraoperative findings, postoperative complications and outcome will be studied.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Exploratory laparotomy during the battle of Mosul, 2016-2017: results from a tertiary civilian hospital in Erbil, Iraqi Kurdistan.
Muhrbeck M, Egelko A, Haweizy RM, von Schreeb J, et al · · 2023 · cited 3× · PMID 37741988 · DOI 10.1186/s12873-023-00882-y -
Exploratory Laparotomy During the Battle of Mosul, 2016–2017: Results from a Tertiary Civilian Hospital in Erbil, Iraqi Kurdistan
Muhrbeck M, Egelko A, Haweizy RM, von Schreeb J, et al · · 2023 · DOI 10.21203/rs.3.rs-2780993/v1
Verify or expand the search:
- PubMed search for NCT03490305
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exploratory laparotomy
Trials testing the same drug.
- NCT06227871 — A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes · completed
Other recruiting trials for Penetrating Abdominal Trauma
Currently open trials in the same condition.
- NCT05127109 — The PASTDUe Nutrition Ecosystem Project (PASTDUe) · Phase 4 · active not recruiting
- NCT07330349 — Alcohol, Psychoactive Drugs, Analgesics and Evaluation in Penetrating Abdominal Trauma · recruiting
Other Vrinnevi Hospital trials
Trials by the same sponsor.
- NCT07347093 — Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study · active not recruiting
- NCT06933303 — Distraction as Treatment for Pain in Children in Resource-scarce Settings · NA · recruiting
- NCT06348589 — Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis · completed
- NCT06399666 — Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03490305 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vrinnevi Hospital
- Last refreshed: 16 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03490305.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing